MedTech, which has historically been a defensive sector, has once again stood its ground even as broader markets have been rattled by the pandemic.
But, digging into the details throws up interesting trends: the resilience is underpinned by clear extremes.
Hence, leveraging the right opportunities assumes a greater importance and is critical to outperformance.
At the upcoming webinar, we will dissect these conflicting trends and share some interesting stock ideas that are best suited to win in a COVID-stricken world.
AlphaValue’s analysts on the sector, Sumit Sayal, Virendra Chauhan and Martin Schnee, Ph.D., just released a new strategy piece on European Medtech companies, including : BioMérieux, Qiagen, Sartorius Stedim, Sartorius, Getinge, and Siemens Healthineers.
Access to report : click here
Founded in 2007, AlphaValue is the world’s leading provider of Independent European Equity and Credit Research. We provide comprehensive, unconflicted research-only (no execution, no corporate finance) coverage of c. 480 European mid and large cap stocks. We have an average of 46% of negative recommendations at any one time. Learn more at www.alphavalue.com